MorrisM., MitchellM.F., SilvaE.G.Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol.1993; 51: 193–196.
2.
MaimanM.A., FruchterR.G., DiMaioT.M.Superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol.1988; 72: 399–403.
3.
FioricaJ.V., RobertsW.S., GreenbergH.Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol.1990; 36: 343–347.
4.
CurtinJ.P., HoskinsW.J., VenkatramanE.S.Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol.1996; 61: 3–10.
5.
GallionH.H., van NagellJ.R.Jr, DonaldsonE.S.Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer.1985; 56: 262–265.
6.
MendenhallW.M., McCartyP.J., MorganL.S.Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafascial hysterectomy beneficial?Int J Radiat Oncol Biol Phys.1991; 21: 899–904.
7.
SardiJ.Sananes C, Giaroli A, et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol.1993; 49: 156–165.
8.
HreschyshynM.M., AronB.S., BoronowR.C.Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys.1979; 5: 317.
9.
OmuraG.A., BlessingJ., VaccarelloL.A randomized trial of cisplatin (C) versus C + mitolactol (CM) versus C + ifosfamide (CIFX) in advanced squamous carcinoma of the cervix (SCC) by the Gynecologic Oncology Group (GOG). Proc Annu Meet Am Soc Clin Oncol.1995; 14: A736.
10.
AaldersJ.G., AbelerV., KolstadP.. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients.Gynecol Oncol.1984; 17: 85–103.
11.
PiverM.S., BarlowJ.J., LeleS.B.. Incidence of subclinical metastasis in stage I and II ovarian carcinoma.Obstet Gynecol.1978; 52: 100–104.
12.
HoskinsW.J., McGuireW.P., BradyM.F.The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.Am J Obstet Gynecol.1994; 170: 974–980.
13.
RobertsW.S.. Cytoreductive surgery in ovarian cancer: why, when, and how?Cancer Control: JMCC.1996; 3: 130–136.
14.
YoungR.C., WaltonL.A., EllenbergS.S.Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomized trials.N Engl J Med.1990; 322: 1021–1027.
15.
ColomboN., ChiariS., MaggioniA.Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy.Gynecol Oncol.1994; 55: S47–S51.
16.
McGuireW.P., HoskinsW.J., BradyM.F.Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.N Engl J Med.1996; 334: 1–6.
17.
van der BurgM.E., van LentM., BuyseM.The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer: Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.N Engl J Med.1995; 332: 629–634.
18.
AlbertsD.S., LiuP.Y., HanniganE.V.Phase III study of intraperitoneal (ip) cisplatin (CDDP)/intravenous (iv) cyclophosphamide (CPA) vs iv CDDP/iv CPA in patients (pts) with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG intergroup study (INT 0051).Proc Annu Meet Am Soc Clin Oncol.1995; 14: A760.
19.
HoskinsW.J., RubinS.C., DulaneyE.Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian cancer.Gynecol Oncol.1989; 34: 365–371.
20.
CavanaghD., FioricaJ.V., HoffmanM.S.Invasive carcinoma of the vulva: changing trends in surgical management.Am J Obstet Gynecol.1990; 163: 1007–1015.
21.
HomesleyH.D., BundyB.N., SedlisA.Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes.Obstet Gynecol.1986; 68: 733–740.
22.
CavanaghD., ShepherdJ.H.. The place of pelvic exenteration in the primary management of advanced carcinoma of the vulva.Gynecol Oncol.1982; 13: 318–322.
